Hormonal and Hematological Imbalance and Female Infertility

Authors

  • Meena S. Farman Department of Biology, College of Science, University of Anbar, Al-Anbar, IRAQ.
  • Marwa Azeez Akoul Department of Biology, College of Science, University of Anbar, Al-Anbar, IRAQ.
  • Rana Hazim Hamoode Department of Basic Sciences, College of Dentistry, University of Anbar, Al-Anbar, IRAQ.

Keywords:

PCOS, Leptin, Inhibin-B, SHBG, PAI-1

Abstract

Poly cystic ovary synrdome (PCOS) is a common endocrinological disorder among women of the reproductive stage. The current study was conducted to evaluate some hormonal and hematological alterations in patients with poly cystic ovarian syndrome (PCOS), BMI or the body mass index was determined for all women, serum hormones (SHBG), Estradiol, DHEAs, Leptin, Inhibin-B, were measured, and hematological changes include PAI-1 activity, fibrinogen and t-PA antigen also measured. The results of the present study showed, there were significant increase (p<0.05) in BM, DHEAs, Leptin, Inhibin-B, PAI-1, fibrinogen and t-PA antigen in PCOS women compared with the control group, but a significant decrease  (p>0.05) in SHBG and E2

Downloads

Download data is not yet available.

References

Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F.,Futterweit, W., & Witchel, S. F. (2009). The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertility and sterility, 91(2), 456-488

Al-Hakeim, H. K., & Ridha, M. A. S. (2013). Study of Activin A and Inhibin A Hormones levels in polycystic ovarian syndrome and their correlation with other biochemical parameters. Al-Kufa University Journal for Biology, 5(2), 86-93.‏

Nasrat, H., Patra, S. K., Goswami, B., Jain, A., & Raghunandan, C. (2015). Study of association of leptin and insulin resistance markers in patients of PCOS. Indian Journal of Clinical Biochemistry, 31(1), 104-107.‏

Witchel, S. F., Teede, H. J., & Pena, A. S. (2019). Curtailing PCOS. Pediatric research, 87(2), 353-361.‏

Al-Jumaili, F. T., Naji, A. J., & Jasim, T. M. (2015). Evaluation of Some Biochemical Markers in Patient's with Polycystic Ovarian Syndrome. Jornal of Biotechnology Research Center, 9(2), 37-45.‏

Krishnan, A., & Muthusami, S. (2016). Hormonal alterations in PCOS and its influence on bone metabolism. Journal of Endocrinology, 232(2), R99-R113.

Mannerås-Holm, L., Baghaei, F., Holm, G., Janson, P. O., Ohlsson, C., Lönn, M., & Stener-Victorin, E. (2011). Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism, 96(4), 1068-1076.

Magoffin, D. A., & Jakimiuk, A. J. (1998). Inhibin A, inhibin B and activin A concentrations in follicular fluid from women with polycystic ovary syndrome. Human reproduction (Oxford, England), 13(10), 2693-2698.

Roberts, V. J., Barth, S. A. R. A., el-Roeiy, A. L. B. E. R. T., & Yen, S. S. (1993). Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. The Journal of Clinical Endocrinology & Metabolism, 77(5), 1402-1410.‏

Segal, S., Elmadjian, M., Takeshige, T., Karp, S., Mercado, R., & Rivnay, B. (2010). Serum inhibin A concentration in women with polycystic ovarian syndrome and the correlation to ethnicity, androgens and insulin resistance. Reproductive biomedicine online, 20(5), 675-680.‏

Gils, A., & Declerck, P. J. (2004). Plasminogen activator inhibitor-1. Current medicinal chemistry, 11(17), 2323-2334.

Mutch, N. J., Wilson, H. M., & Booth, N. A. (2001). Plasminogen activator inhibitor-1 and haemostasis in obesity. Proceedings of the Nutrition Society, 60(3), 341-347.‏

Sales, M. F., Soter, M. O., Candido, A. L., Fernandes, A. P., Oliveira, F. R., Ferreira, A. C. S., ... & Gomes, K. B. (2013). Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome. Gynecological Endocrinology, 29(10), 936-939.‏

Barber, T. M., Hanson, P., Weickert, M. O., & Franks, S. (2019). Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clinical Medicine Insights: Reproductive Health, 13, 1-9.

Al-Deresaw ,M.S.( 2012).Hormonal disturbance in Iraqi women patients with Polycystic ovary syndrome (PCOS). Wasit Journal for Science & Medicine, 5 (2): (67-73).

Kadium, D. A. H., Kaem, G. G., Al Saeq, Z. M., & Al Safar, Z. A. (2016). The relationship between male testosterone hormone and some female hormones in women with polycystic ovary syndrome (PCOS). Journal of Contemporary Medical Sciences, 2(5), 20-24.‏

Oh, J. Y., Sung, Y. A., Lee, H. J., Oh, J. Y., Chung, H. W., & Park, H. (2010). Optimal waist circumference for prediction of metabolic syndrome in young Korean women with polycystic ovary syndrome. Obesity, 18(3), 593-597.

Vicennati, V., Gambineri, A., Calzoni, F., Casimirri, F., Macor, C., Vettor, R., & Pasquali, R. (1998). Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels. Metabolism, 47(8), 988-992.‏

Telli, M. H., Yildirim, M., & Noyan, V. (2002). Serum leptin levels in patients with polycystic ovary syndrome. Fertility and Sterility, 77(5), 932-935.‏

Lockwood, G. M. (2000). The role of inhibin in polycystic ovary syndrome. Human Fertility, 3(2), 86-92.‏

Hassan, A. E. (2012). The effect of inhibin B on ovarian response in subjects with polycystic ovary. Journal of the Faculty of Medicine, 54(1), 100-105.‏

Wachs, D. S., Coffler, M. S., Malcom, P. J., Shimasaki, S., & Chang, R. J. (2008). Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism, 93(5), 1827-1833.‏

Anderson, R. A., Groome, N. P., & Baird, D. T. (1998). Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono‐ovulation. Clinical endocrinology, 48(5), 577-584.‏

Juhan‐Vague, I., Alessi, M. C., Mavri, A., & Morange, P. E. (2003). Plasminogen activator inhibitor‐1, inflammation, obesity, insulin resistance and vascular risk. Journal of Thrombosis and Haemostasis, 1(7), 1575-1579.‏

Sprengers, E. D., & Kluft, C. (1987). Plasminogen activator inhibitors. Blood, 69(2), 381-387.

Aso, Y. (2007). Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis. Front Biosci, 12(8), 2957-2966.‏

Kelly, C. J., Lyall, H., Petrie, J. R., Gould, G. W., Connell, J. M., Rumley, A., ... & Sattar, N. (2002). A specific elevation in tissue plasminogen activator antigen in women with polycystic ovarian syndrome. The Journal of Clinical Endocrinology & Metabolism, 87(7), 3287-3290.‏

Downloads

Published

2021-03-31

How to Cite

Meena S. Farman, Marwa Azeez Akoul, & Rana Hazim Hamoode. (2021). Hormonal and Hematological Imbalance and Female Infertility. International Journal for Research in Applied Sciences and Biotechnology, 8(2), 286–289. Retrieved from https://ijrasb.com/index.php/ijrasb/article/view/83

Issue

Vol. 8 No. 2 (2021): March Issue

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.